POSC275 Impact on Bluebird's Withdrawal from the German Market on Funding for Gene Therapies
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.913
https://www.valueinhealthjournal.com/article/S1098-3015(21)02708-X/fulltext
Section Title :
Section Order :
10443
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02708-X&doi=10.1016/j.jval.2021.11.913